IGF 1, BDNF, and NGF mediate the neuro-modulatory role of stem cells in acrylamide-induced hippocampal toxic changes in rats
Abstract
Background: Acrylamide (ACR), a common industrial chemical, is a strong neurotoxic material. The hippocampus is a brain area of interest mostly affected by Alzheimer’s disease. Mesenchymal stem cells (MSCs) usefulness in various neurological diseases including Alzheimer’s is being debated. In this work, the authors aim to explore the role of MSCs in ACR-induced hippocampal neurodegeneration and elucidate the mediating mechanism.
Materials and methods: For this purpose, ten rats served as control, another ten were injected ACR (i.p. 50 mg/kg/day for 2 weeks), and the last ten rats were injected ACR in addition to MSCs (i.p. 1 × 107 MSCs single injection).
Results: ACR induced neurodegenerative histopathological hippocampal changes and adversely altered hippocampal oxidative stress markers SOD, MDA, and GSH. ACR had induced hippocampal demyelination as detected by silver staining. ACR significantly (P < 0.05) up-regulated the ELISA hippocampal TNF-alpha and IL-6 and produced microglial & astrocyte activation (as tracked by Iba1 & GFAP immunohistochemistry respectively). ACR significantly reduced hippocampal PCR gene expression of IGF 1 (insulin growth factor-1), BDNF (brain-derived neurotrophic factor), and NGF (nerve growth factor). MSCs administration had mitigated all the previous deleterious changes.
Conclusions: Acrylamide caused detrimental effects on the hippocampus and demonstrably altered the hippocampal architecture. Bone marrow mesenchymal stem cells offered a promising therapeutic role against these neurotoxic effects of acrylamide, presumably through modulation of IGF 1, BDNF, and NGF gene expressions.
Keywords: acrylamidestem cellshippocampusIGF 1BDNFNGF
References
- An S, Shi J, Li Z, et al. The effects of acrylamide-mediated dorsal root ganglion neurons injury on ferroptosis. Hum Exp Toxicol. 2022; 41: 9603271221129786.
- Andrzejewska A, Dabrowska S, Lukomska B, et al. Mesenchymal stem cells for neurological disorders. Adv Sci (Weinh). 2021; 8(7): 2002944.
- Chi H, Guan Y, Li F, et al. The effect of human umbilical cord mesenchymal stromal cells in protection of dopaminergic neurons from apoptosis by reducing oxidative stress in the early stage of a 6-OHDA-induced Parkinson's disease model. Cell Transplant. 2019; 28(1_suppl): 87S–99S.
- Erdemli ME, Arif Aladag M, Altinoz E, et al. Acrylamide applied during pregnancy causes the neurotoxic effect by lowering BDNF levels in the fetal brain. Neurotoxicol Teratol. 2018; 67: 37–43.
- Fan XL, Zhang Y, Li X, et al. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020; 77(14): 2771–2794.
- Gong J, Xiong Z, Yu W, et al. Bone marrow mesenchymal stem cells alleviate acute severe pancreatitis and promote lung repair via inhibiting NLRP3 inflammasome in rat. Dig Dis Sci. 2024; 69(1): 135–147.
- Guo J, Cao X, Hu X, et al. The anti-apoptotic, antioxidant and anti-inflammatory effects of curcumin on acrylamide-induced neurotoxicity in rats. BMC Pharmacol Toxicol. 2020; 21(1): 62.
- Imam RA, Gadallah HN. Acrylamide-induced adverse cerebellar changes in rats: possible oligodendrogenic effect of omega 3 and green tea. Folia Morphol. 2019; 78(3): 564–574.
- Kilic S, Yuksel B, Pinarli F, et al. Effect of stem cell application on Asherman syndrome, an experimental rat model. J Assist Reprod Genet. 2014; 31(8): 975–982.
- Kumar SK, Perumal S, Rajagopalan V. Therapeutic effect of bone marrow mesenchymal stem cells on cold stress induced changes in the hippocampus of rats. Neural Regen Res. 2014; 9(19): 1740–1744.
- Lan XY, Sun ZW, Xu GL, et al. Bone marrow mesenchymal stem cells exert protective effects after ischemic stroke through upregulation of glutathione. Stem Cell Rev Rep. 2022; 18(2): 585–594.
- Li T, Zhang L, Xiong L, et al. Bone marrow mesenchymal stem cells in brain ischemia enhaces axonal regeneration associated with IGF‐1. Ibrain. 2019; 5(4): 50–59.
- Liu Y, Zhang X, Yan D, et al. Chronic acrylamide exposure induced glia cell activation, NLRP3 infl-ammasome upregulation and cognitive impairment. Toxicol Appl Pharmacol. 2020; 393: 114949.
- Noureddini M, Bagheri-Mohammadi S. Adult hippocampal neurogenesis and Alzheimer's disease: novel application of mesenchymal stem cells and their role in hippocampal neurogenesis. Int J Mol Cell Med. 2021; 10(1): 1–10.
- Park HRa, Kim MS, Kim SoJ, et al. Acrylamide induces cell death in neural progenitor cells and impairs hippocampal neurogenesis. Toxicol Lett. 2010; 193(1): 86–93.
- Pennisi M, Malaguarnera G, Puglisi V, et al. Neurotoxicity of acrylamide in exposed workers. Int J Environ Res Public Health. 2013; 10(9): 3843–3854.
- Quan W, Li M, Jiao Ye, et al. Effect of dietary exposure to acrylamide on diabetes-associated cognitive dysfunction from the perspectives of oxidative damage, neuroinflammation, and metabolic disorders. J Agric Food Chem. 2022; 70(14): 4445–4456.
- Rafaiee R, Ahmadiankia N, Mousavi SA, et al. Bone marrow mesenchymal stem cells improve cognitive impairments induced by methamphetamine in rats and reduce relapse. Bioimpacts. 2023; 13(2): 97–108.
- Rand D, Cooper I. Caspase-1: an important player and possible target for repair of the blood-brain barrier underlying neurodegeneration. Neural Regen Res. 2021; 16(12): 2390–2392.
- Skok M, Deryabina O, Lykhmus O, et al. Mesenchymal stem cell application for treatment of neuroinflammation-induced cognitive impairment in mice. Regen Med. 2022; 17(8): 533–546.
- Stavely R, Nurgali K. The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl Med. 2020; 9(9): 985–1006.
- Tabeshpour J, Mehri S, Abnous K, et al. Role of oxidative stress, MAPKinase and apoptosis pathways in the protective effects of thymoquinone against acrylamide-induced central nervous system toxicity in rat. Neurochem Res. 2020; 45(2): 254–267.
- Tfilin M, Sudai E, Merenlender A, et al. Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol Psychiatry. 2010; 15(12): 1164–1175.
- Thabet NM, Moustafa EM. Protective effect of rutin against brain injury induced by acrylamide or gamma radiation: role of PI3K/AKT/GSK-3β/NRF-2 signalling pathway. Arch Physiol Biochem. 2018; 124(2): 185–193.
- Üremiş MM, Üremiş N, Gül M, et al. Acrylamide, applied during pregnancy and postpartum period in offspring rats, significantly disrupted myelination by decreasing the levels of myelin-related proteins: MBP, MAG, and MOG. Neurochem Res. 2024; 49(3): 617–635.
- Wang Q, Sun G, Gao C, et al. Bone marrow mesenchymal stem cells attenuate 2,5-hexanedione-induced neuronal apoptosis through a NGF/AKT-dependent pathway. Sci Rep. 2016; 6: 34715.
- Wang TB, He Y, Li RC, et al. Rosmarinic acid mitigates acrylamide induced neurotoxicity via suppressing endoplasmic reticulum stress and inflammation in mouse hippocampus. Phytomedicine. 2024; 126: 155448.
- Zakrzewski W, Dobrzyński M, Szymonowicz M, et al. Stem cells: past, present, and future. Stem Cell Res Ther. 2019; 10(1): 68.
- Zappa Villar MF, López Hanotte J, Pardo J, et al. Mesenchymal stem cells therapy improved the streptozotocin-induced behavioral and hippocampal impairment in rats. Mol Neurobiol. 2020; 57(2): 600–615.
- Zhang Bo, Li H, Wang Y, et al. Mechanism of autophagy mediated by IGF-1 signaling pathway in the neurotoxicity of lead in pubertal rats. Ecotoxicol Environ Saf. 2023; 251: 114557.
- Zhang JM, Wang H, Fan YY, et al. Effect of mesenchymal stem cells transplantation on the changes of oligodendrocyte lineage in rat brain with experimental autoimmune encephalomyelitis. Brain Behav. 2021; 11(2): e01999.
- Zhao M, Zhang B, Deng L. The mechanism of acrylamide-induced neurotoxicity: current status and future perspectives. Front Nutr. 2022; 9: 859189.
- Zong C, Hasegawa R, Urushitani M, et al. Role of microglial activation and neuroinflammation in neurotoxicity of acrylamide in vivo and in vitro. Arch Toxicol. 2019; 93(7): 2007–2019.
